Nine analysts gave Nashville, Tenn.-based Surgery Partners a "buy" rating, according to The Cerbat Gem.
Here are five key notes:
1. The analysts have an average 12-month price target of $20.86.
2. On Jan. 17, 2017, Jeffries Group gave the company a $24 price target.
3. Surgery Partners opened Jan. 19, 2017, trading at $18 per share.
4. The company's market cap. totals $872.87 million.
5. The P/E ratio is 92.78.